Tregs also affect tumor-infiltrating pDCs and secrete the suppressive cytokines IL-10 and TGF-β, which alter the pDC phenotype, inhibit immune activation through the classical pathway, impair IFN-α production by pDCs, and enhance tumor immunosuppression79. The gene discussed is IL10; the disease is neoplasm.